Nektar Therapeutics recently completed a follow-on equity offering of about US$325.00 million and later closed an underwritten public offering totaling…
Read More

Nektar Therapeutics recently completed a follow-on equity offering of about US$325.00 million and later closed an underwritten public offering totaling…
Read More